Medallion, which will be led by Donald Deyo, a former Medtronic executive, is developing implantable drug delivery infusion pumps to provide improved safety, connectivity and molecular infusion capabilities, according to the report.
“These capabilities address both the requirements of currently approved clinical indications, as well as enable future expansion into new indications in areas such as diabetes and neurodegenerative disease,” reads the report.
More Articles on the Medical Device Market:
4 Latest Medical Device Recalls
Global Medical Electrode Market to Reach $2B by 2020
Physicians Turning to 3-D Printing to Develop Pediatric Devices
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
